Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|October 24, 2022
Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patientsMatthias Becker, Anne Cossmann, Karsten Lürken, et al.
Scientific Reports|May 3, 2022
COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutantsDaniel Junker, Alex Dulovic, Matthias Becker, et al.
Vaccines|July 30, 2025
XBB.1.5 COVID-19 mRNA Vaccines Induce Inadequate Mucosal Immunity in Patients with Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 26, 2023
Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panelManuela Harries, Veronika K Jaeger, Isti Rodiah, et al.
EMBO Reports|April 27, 2021
NeutrobodyPlex-monitoring SARS-CoV-2 neutralizing immune responses using nanobodiesTeresa R Wagner, Elena Ostertag, Philipp D Kaiser, et al.
Alimentary Pharmacology & Therapeutics|October 29, 2024
XBB.1.5-Adapted COVID-19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS-CoV-2 JN.1 Variant in Patients With Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Vaccines|July 27, 2024
Systemic and Mucosal Immunogenicity of Monovalent XBB.1.5-Adapted COVID-19 mRNA Vaccines in Patients with Inflammatory Bowel DiseaseSimon Woelfel, Joel Dütschler, Daniel Junker, et al.
Alimentary Pharmacology & Therapeutics|August 12, 2023
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel diseaseSimon Woelfel, Joel Dütschler, Marius König, et al.
Scientific Reports|July 18, 2025
Longitudinal analysis of humoral and cellular immunity in SARS-CoV-2 exposed familiesAlex Dulovic, Armin Rabsteyn, Jonathan Remppis, et al.
Nature Communications|May 26, 2021
Immune response to SARS-CoV-2 variants of concern in vaccinated individualsMatthias Becker, Alex Dulovic, Daniel Junker, et al.
Pageof 4